For citations:
Kosolapov E.G., Kochenkov F.S., Pogudina N.L., Blinov D.V. COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2017;10(2):31-40. (In Russ.) https://doi.org/10.17749/2070-4909.2017.10.2.031-040
Views PDF (Rus): 628
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 